Top Large Cap Negative Movers: SION: -91% Topline Data from Two Development Programs in Cystic Fibrosis and Provides Corporate Update MLTX
Top Large Cap Negative Movers: SION: -91% Topline Data from Two Development Programs in Cystic Fibrosis and Provides Corporate Update MLTX: -15% Announces Positive Topline Results from the Phase 3 IZAR-1 Trial of Sonelokimab MNDY: -11% Earnings CEVA: -7% Earnings SIMO: -5% Earnings B: -4% Earnings INTC: -3.5% Offering